drugset / Trial / NCT02345902

Treatment of Hypoactive Delirium and Outcome Measures

NCT02345902

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Haloperidol and Non-Pharmacologic Treatment are recognized treatments for delirium. This study will evaluate which is the best treatment for hypoactive delirium.

Timeline

Start
2016-01
Primary completion
2018-03
Completion
2018-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Haloperidol Other / unclassified 1.25 mg Oral

Indications